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ABSTRACT 
Purpose:  To evaluate the accuracy of electron beam dose calculations in MVCT images containing lead 
alloy masks. 
Method and Materials:  A phantom consisting of two 30x30x5 cm3 slabs of CIRS plastic water® was 
imaged using kVCT (GE Lightspeed-RT) and MVCT (TomoTherapy Hi·Art).  Nine MVCT scans were 
taken with different square masks of lead alloy (Cerrobend®, density = 9.4 g·cm-3) on top of the phantom.  
The masks contained square apertures of 3x3 cm2, 6x6 cm2 and 10x10 cm2 and had thicknesses of 6 mm, 8 
mm and 10 mm.  The same collimation was simulated in the kVCT images by creating regions-of-interest 
(ROI) duplicating the sizes, shapes, and density of the masks.  Using the Philips Pinnacle3 treatment 
planning system, twelve treatment plans were created for the combination of four electron energies (6, 9, 
12, and 16 MeV) and the three apertures. For each plan, the mask thickness appropriate for the electron 
energy was used and the dose distributions calculated using the kVCT and MVCT images were compared.  
In uniform dose regions dose differences were calculated; in high dose-gradient regions distances-to-
agreement (DTA) were measured. 
Results:  In the uniform dose region, the maximum differences of doses in the MVCT images from doses 
in the kVCT images were greater than or equal to ±5% for all but one opening and energy combination.  In 
the high dose-gradient region, more than half of the maximum DTA values exceeded 2 mm.  Analysis of 
the MVCT images showed that the differences were largely due to two errors.  First, the presence of the 
masks caused distortions in the MVCT numbers such that the calculated dose in the MVCT images 
penetrated less deeply.  Second, distortion in the shape of the image of the collimation caused the 
calculation algorithm to scatter excess electrons into the central axis of the beam. 
Conclusion:  The presence of Cerrobend® masks in MVCT imaging produces distortions in the CT 
numbers that make electron beam dose calculations insufficiently accurate for electron beam treatment 
planning.  
 
Supported in part by a research agreement with TomoTherapy, Inc. 
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Chapter 1 Introduction 
 
1.1 Function of skin collimation in treatment delivery 
Surface (skin) collimation is often used in electron beam therapy for the purposes of sparing 
critical structures adjacent to the target by shaping the radiation beam and blocking leakage dose due to 
scattered electrons (Hogstrom et al 1991).  Skin collimation is also used in conjunction with off-surface 
bolus (scatter plate) to restore the sharp beam penumbra after the beam has been scattered and the energy 
degraded by the scatter plate (Hogstrom et al 1991).  Because of the superficiality of some cancers in the 
head and neck region and the importance of avoiding nearby critical structures, skin collimation is most 
often used in the treatment of cancers in this area.  Cancers in the head and neck most often treated with 
electrons and requiring collimation include basal cell and squamous cell carcinomas of the eyelids, lip, tip 
of nose and ear (Tapley et al 1976).  The accurate positioning of skin collimation within the beam is very 
important when setting up the patient for treatment.  The skin collimation must have its inner edge inside 
the penumbra cast by the geometric (light) field edge of the uncollimated beam and its outer edge must 
extend well past the geometric field edge (Hogstrom et al 1991).  This maintains the dose uniformity within 
the treatment field by narrowing the penumbra and, where used in conjunction with a scatter plate, protects 
the patient from dose from scattered electrons (Hogstrom et al 1991).   
1.2 Incorporating skin collimation in treatment planning 
For accurate dose calculation, the skin collimation must be accurately included in the treatment 
planning process.  Current commercial treatment planning systems have neither accurate nor efficient 
method for doing this because of software limitations and problems in imaging with skin collimation. 
There are two straightforward potential methods for adding skin collimation into the treatment 
planning process.  The first method, currently used in the Mary Bird Perkins Cancer Center (MBPCC), is to 
manually draw the skin collimation onto the transverse CT images as an anatomic structure after the scan 
(Fig 1).  After the structure has been created, its density can be changed to that of Pb (11.3 g·cm-3) or 
Cerrobend® (9.4 g·cm-3).  However, this process is subjective, inaccurate, and time consuming.  To my 
knowledge, no commercial treatment planning systems presently have software capabilities for easily 
adding skin collimation so that contours must be entered manually, slice by slice.  The skin collimation can 
be contoured by following the outline of the patient surface which is clearly seen on the CT image (Fig 1).  
Most importantly, the beam-defining edges of the collimator must be correct on every slice, matching the 
daily setup.  Uniformity of thickness of the collimation is not important so long as it stops the electron (in 
the clinic the actual masks used for daily treatments are of uniform thickness).  The minimum thickness 
must equal or exceed the range of the electrons for the energy of the electron beam.  Similarly, treatment 
planning systems have no methods for modeling the scatter plate so that it must be manually contoured, a 
task even more difficult than drawing the skin collimation.  However, the problem of the scatter plate is not 
addressed in this research. 
 
 
 
 
Figure 1.  Skin collimation and scatter plate drawn onto the kVCT images in the treatment planning system. 
skin 
collimation 
scatter plate 
beam direction 
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A possible second method is to CT scan the patient with the constructed skin collimation in place 
so that it is contained in the image set. However, there is a physical limitation to the accuracy of this 
solution with conventional CT scanners because of the low photon energy of kVCT.  Kilovoltage photons 
are greatly attenuated in the presence of high-Z materials such as Cerrobend® so that detector signals are 
very small for paths that transverse such materials (Coolens et al 2003).  This high attenuation is not well 
modeled by conventional CT image reconstruction algorithms, resulting in extreme distortions and streak 
artifacts in the images (Yazdia et al 2005) (Fig 2).  Dose calculations will therefore be inaccurate when 
using kVCT images acquired with skin collimation in place.   
 
   
      (a)           (b) 
       
Figure 2.  (a) Axial kVCT image of a CIRS plastic water® phantom with 1cm of Cerrobend® on top, 
demonstrating the streaking and distortions produced in kVCT images by high-Z materials; (b) photograph 
of phantom and Cerrobend®. 
 
1.3 MVCT as a potential solution to treatment planning with skin collimation 
It has been observed that high-density materials (e.g. aluminum, titanium, and copper) produce 
dramatically less distortion in MVCT images than in kVCT images (Ozer et al 2006, Meeks et al 2006).  A 
potential solution to part of the problem of treatment planning with skin collimation is to scan the patient 
with the skin collimation in place using MVCT.  This would avoid the inaccurate and time consuming 
process of manual contouring.  Megavoltage photons are less attenuated by high-Z materials such as 
Cerrobend®, which means that more photons penetrate the skin collimation and are registered by the 
detectors.  This produces more accurate reconstruction with conventional algorithms, giving more accurate 
CT numbers and less streaking artifacts.  MVCT image sets are also more relevant for treatment planning 
because the CT numbers are directly related to electron density, making them more relevant than kVCT for 
dose calculations and inhomogeneity corrections (Ruchala et al 1999). 
The TomoTherapy Hi·Art® system, one of which is owned by MBPCC, has an onboard MVCT 
scanner (3.5 MV) for image guided radiation therapy (IGRT). It is capable of scanning a patient and 
sending the images to a Philips Pinnacle3 treatment planning system (TPS) for dose calculations.  Figure 3 
shows an image of the same setup as Figure 2 (plastic water® phantom with skin collimation) taken with 
TomoTherapy MVCT.  The amount of streaking and image distortion normally due to high-Z Cerrobend® 
is dramatically reduced, clearly highlighting MVCT’s potential usefulness.  This improvement in image 
quality could potentially enable Monte Carlo algorithms or a recommissioned pencil beam redefinition 
algorithm (PBRA) to correctly calculate dose in the presence of multiple beam modifiers such as skin 
collimation and scatter plate.   
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Figure 3.  Axial MVCT image of a CIRS plastic water® phantom with 1cm of Cerrobend® on top, 
demonstrating reduced streaking and distortions in MVCT images with high-Z materials. 
 
1.4 Purpose 
The goal of this research is to investigate the use of MVCT imaging of phantoms with skin 
collimation in place for the purpose of electron beam treatment planning. 
1.5 Hypothesis 
 The hypothesis of this research is that using MVCT images with skin collimation for treatment 
planning, doses delivered from 6-16 MeV electron beams can be calculated to ±5% dose difference 
agreement in the uniform-dose region and ±2mm distance-to-agreement in high dose-gradient regions 
compared to doses calculated using kVCT images with manually contoured skin collimation.  The uniform 
dose region is defined as those doses >90% of the maximum dose along the central axis for a 10x10 cm2 
open field at 100 cm SSD and the high dose-gradient region is defined as 10%<doses<90% of the 
maximum dose along the central axis for a 10x10 cm2 open field at 100 cm SSD.    
1.6 Specific aims 
Aim 1.  Construct CT number-to-density tables for MVCT and kVCT images.   
Aim 2.  Compare dose calculations in MVCT and kVCT images of a plastic water phantom 
without skin collimation.  
Aim 3.  Compare dose calculations in MVCT and kVCT images of a head phantom and patient 
without skin collimation.   
Aim 4.  Construct Cerrobend® masks to simulate the range of dimensions of skin collimation used 
in the clinic.   
Aim 5.  Compare doses calculated on MVCT images of a plastic water® phantom with skin 
collimation in place to doses calculated on kVCT images of the same phantom with skin 
collimation drawn onto the images during treatment planning.   
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Chapter 2 Aim 1 
 
2.1 Aim 1:  Construct CT number-to-density tables for MVCT and kVCT images 
TomoTherapy MVCT images are currently used for image-guided radiation therapy (IGRT) at 
MBPCC but not for clinical dose calculations.  Consequently, there is no clinically available CT number-
to-density conversion table. The purpose of this aim was to generate MV and kV CT number-to-density 
conversion tables for the dose calculations in Aims 2, 3 and 5. 
2.2 Methods and materials 
A CIRS model 062 electron density phantom was scanned.  This phantom is composed of an outer 
‘torso’ and an inner ‘head’ section and has a series of plugs of known physical densities (Figs 4, 5).  A CT 
scan of the phantom provided a relationship between CT number and physical density for both kVCT and 
MVCT images.  The relationships are tabulated and entered into Pinnacle3 for its dose calculations. 
 
 
Figure 4.  CIRS model 062 phantom. 
 
2.2.1 MVCT density tables 
To create a measured MVCT number-to-density table, the CIRS ‘torso’ phantom was scanned two 
consecutive times using the “Fine” slice thickness (2 mm) on the TomoTherapy unit.  The whole ‘torso’ 
was scanned rather than simply the ‘head’ in order to include the maximum number of inserts.  The 
resulting images were transferred to Pinnacle3.  Using the contouring tools of Pinnacle3, a circular region-
of-interest (ROI) was created within the image of each insert (Fig 5).  The ROI was at least 5 mm in 
diameter and no bigger than 15 mm in diameter in order to sample a large number of pixels at the center of 
the insert and to avoid CT number variations at the edges of the 29.5-32.5 mm inserts.  Pinnacle3 calculated 
and reported the mean CT number in each ROI.  The reported CT numbers from the two sets of scans were 
averaged and used to create a CT number-to-density table.   
insert  
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Figure 5.  Axial MVCT image of CIRS model 062 electron phantom. 
 
         To minimize the effect of possible fluctuations in CT numbers between measurement days, scans of 
the CIRS phantom to generate CT number-to-density conversion tables were performed on the same days 
as the image sets were acquired for dose calculations.  A total of four separate tables were created.   
 
2.2.2 kVCT density tables 
The CIRS phantom was scanned on the GE Lightspeed RT scanner to produce a kVCT number-to-
density conversion table (Fig 6).  The scanner was set at 120kVp and the slice thickness was 2.5 mm 
instead of 2 mm.  The average of two scans taken on the same day was used for the CT numbers. 
 
 
Figure 6.  Axial kVCT image of CIRS model 062 electron phantom  
2.3 Creation of aim-specific CT number-to-density tables 
Three of the four tables created for the MVCT image dose calculations and the one table created 
for the kVCT image dose calculations were modified in order that the CT number for plastic water 
correctly predict its collision stopping power ratio.  In calculating electron beam doses, Pinnacle3 
determines collision stopping power and angular scattering power ratios from physical density, which is 
determined from a CT number.  Therefore, the physical densities in the CT number-to-density tables were 
altered to relate the proper collision stopping power and angular scattering power ratios to CT numbers.  
The stopping power for water (S/ρ)water for electrons is 1.968 MeV·g-1·cm2 and the stopping power for CIRS 
plastic (S/ρ)plastic for electrons is 1.971 MeV·g-1·cm2.  This results in a relative stopping power of 1.002, 
region-of-
interest on 
insert 
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which in the Pinnacle3 lookup table corresponds to a density of 0.981 MeV·g·cm-3 (Table 1).  Therefore, in 
order for Pinnacle3 to use the correct stopping power and angular scattering power ratios for the phantom 
calculations in Aims 2, 3 and 5, the densities in the CT number-to-density tables were modified by a 
correction factor that produced a density value of 0.981 for the phantom density. 
 
Table 1.  Patient collision stopping power and angular scattering power data. 
Physical Density 
(g·cm-3)        Collision Stopping Power Ratio Angular Scattering Power Ratio 
0.000 0.001 0.001 
0.291 0.311 0.292 
0.927 0.933 0.729 
1.000 1.027 0.912 
1.047 1.051 1.040 
1.100 1.098 1.135 
1.427 1.422 1.863 
1.940 1.940 3.026 
2.900 11.300 11.900 
 
2.3.1 Aim 2 and Aim 5 modified tables 
The modified MVCT number-to-density table used for Aim 2 was created from the table measured 
on November 21, 2006.  A CIRS plastic water® phantom, consisting of two slabs of size 30x30x5 cm3, was 
scanned on the same day and an ROI was drawn in the center to obtain a mean CT number.  The mean CT 
number was 1032, which corresponded to a density value of 1.020 g·cm-3.  Therefore, the densities in the 
range from 0.967 g·cm-3 to 1.07 g·cm-3 were scaled by a factor of 0.964 (=0.981/1.020).  This same factor 
was applied to the same range of densities for the MVCT number-to-density tables used for the dose 
calculations done in Aim 5.   
The modified kVCT number-to-density table used for Aim 2 was similarly modified.  The mean 
CT number measured for the plastic water phantom was 1075, which corresponded to a density value of 
1.080 g·cm-3.  Therefore, densities in the kVCT table in the range from 0.495 g·cm-3 to 1.16 g·cm-3 were 
scaled by a factor of 0.910 (=0.981/1.080).                 
                   
2.3.2 Aim 3 modified tables 
The modified MVCT number-to-density table used for Aim 3 was created from the table measured 
on November 28, 2006.  The CIRS model 065 radiosurgery head phantom was scanned on the same day 
and an ROI drawn in a section of soft tissue to obtain a mean CT number.  The mean CT number was 1066, 
which corresponded to a density value of 1.063 g·cm-3.  Therefore, the densities in the range from 0.967 
g·cm-3 to 1.07 g·cm-3 were scaled by a factor of 0.923 (=0.981/1.063).   
The modified kVCT number-to-density table was created in the same way except that the mean 
CT number was 1032, which corresponded to a density value of 1.032 g·cm-3.  Therefore, densities in this 
table in the range from 0.967 g·cm-3 to 1.07 g·cm-3 were reduced by a factor of 0.950 (=0.981/1.03).   
 
2.4 Results 
Four MVCT number-to-density conversion tables were measured and three modified tables were 
created.  Each table was date-specific, meaning that it was used to calculate doses only for the images 
acquired on the same day as the measurement of the table.  The measured tables show good consistency 
over the fifteen days that the data were acquired (Table 3).  The table used to calculate dose in the patient 
(November 13, 2006) was not modified.  The modified data are shown in Table 3.  The measured kVCT 
number-to-density conversion table and its modified version are shown in Table 4. 
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Table 2.  MV CT number-to-density data.  
  Physical 
CT 
number 
CT 
number 
CT 
number 
CT 
number 
Mean and 
standard 
Material Density (g·cm-3) 
Nov, 13 
2006 
Nov, 17 
2006 
Nov, 21 
2006 
Nov, 28 
2006 deviation 
vacuum 0 0 0 0 0 0 ± 0 
air 0.001 2 4 4 1 3 ± 1.5 
lung (inhale) 0.195 231 232 232 232 232 ± 0.5 
lung (exhale) 0.495 504 508 504 507 506 ± 2.1 
adipose 0.967 974 974 974 977 975 ± 1.5 
breast 0.991 1008 1011 1008 1013 1010 ± 2.5 
water 1.000 1022 1020 1017 1019 1020 ± 2.1 
muscle 1.062 1060 1064 1061 1065 1063 ± 2.4 
liver 1.071 1076 1077 1076 1080 1077 ± 1.9 
trabecular 
bone 1.161 1148 1148 1146 1151 1148 ± 2.1 
dense bone 1.609 1504 1508 1506 1507 1506 ± 1.7 
 
 
Table 3.  Modified MV CT number-to-density tables. 
  Physical 
Aim 2 modified 
physical density 
(g·cm-3) 
Aim 3 modified 
physical density 
(g·cm-3) 
Aim 5 modified 
physical density 
(g·cm-3) 
Aim 5 modified 
physical density 
(g·cm-3) 
Material density (g·cm-3) Nov 21, 2006 Nov 28, 2006 Nov 17, 2006 Nov 28, 2006 
vacuum 0.000 0.000 0.000 0.000 0.000 
air 0.001 0.001 0.001 0.001 0.001 
lung (inhale) 0.195 0.195 0.195 0.195 0.195 
lung (exhale) 0.495 0.495 0.495 0.495 0.495 
adipose 0.967 0.929 0.893 0.933 0.932 
breast 0.991 0.952 0.915 0.956 0.955 
water 1.000 0.961 0.923 0.965 0.964 
muscle 1.062 1.021 0.980 1.025 1.024 
liver 1.071 1.029 0.989 1.034 1.032 
trabecular bone 1.161 1.161 1.161 1.161 1.161 
dense bone 1.609 1.609 1.609 1.609 1.609 
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Table 4.  Measured and modified kV CT number-to-density data. 
   Physical  
Aim 2 modified 
physical  Aim 3 modified physical  
Material  CT number density (gcm-3) density (gcm-3) density (gcm-3) 
vacuum 0 0 0 0 
air 2 0.001 0.001 0.001 
lung (inhale) 223 0.195 0.195 0.195 
lung (exhale) 495 0.495 0.479 0.495 
adipose 939 0.967 0.880 0.919 
breast 976 0.991 0.902 0.941 
water 1008 1.000 0.910 0.950 
muscle 1054 1.062 0.966 1.009 
liver 1062 1.071 0.975 1.017 
trabecular 
bone 1242 1.161 1.057 1.161 
dense bone 1927 1.609 1.537 1.609 
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Chapter 3 Aim 2 
 
3.1 Aim 2:  Compare dose calculations in MVCT and kVCT images of a plastic water phantom 
The goal of Aim 2 was to determine the accuracy of electron dose calculations when using MVCT 
images of a plastic water phantom with no skin collimation (no high-Z distortions). 
3.2 Methods and materials 
Two slabs of 30x30x5 cm3 CIRS plastic water® were stacked on top of each other to produce a flat 
surface, water-like phantom that could easily be CT scanned on the GE Lightspeed RT and on the 
TomoTherapy MVCT unit.  This phantom was scanned once on each machine, and  the resulting image sets 
were exported to Pinnacle3 (Fig 7). 
 
Figure 7.  Axial MVCT image of a CIRS plastic water phantom image with the geometry of a 10x10 cm2 
beam. 
 
3.2.1 Treatment planning 
Two simple treatment plans were created on each image set.  The first plan was a 9 MeV beam 
perpendicular to the phantom with an open 10x10 cm2 applicator and a prescription of 100 monitor units 
(MUs) delivered at 100 cm SSD. The second plan had the same parameters and prescription except its 
energy was 16 MeV.  Calculated doses were extracted from the kVCT and MVCT image sets by aligning 
the posterior edge of the dose grid to the posterior edge of the phantom in order to avoid surface distortion 
(Figure 8).  The dose grid had the same dimensions for each set of images.   
The vertical coordinate of the posterior edge of the phantom in both image sets was determined 
using a two step process.  First, the couch was removed from the image set by contouring an ROI aligned to 
the surface of the couch and overriding the density to be that of air.  Second, a point-of-interest (POI) and a 
posterior beam were created.  The beam isocenter was set at the POI and then the SSD of the beam was set 
to 100 cm (Figure 8).  Pinnacle3 has a default threshold density value of 0.60 g/cm3 for identifying the 
surface of the patient.  In determining SSD, Pinnacle3 ray-traces along the central axis of the beam from the 
source until it encounters a voxel with density above the threshold value.  Therefore, the first central-axis 
voxel with density above the threshold was taken as the posterior edge of the phantom.  This method was 
used because it puts the dose grid in the same position relative to the phantom regardless of possible 
distortions in the anterior surface. 
 
Figure 8.  CT scan of plastic water phantom in which the couch was removed by setting its density to 0.000 
g·cm3.  The isocenter point is the intersection of a posterior beam at 100 cm SSD with the phantom surface. 
phantom 
couch  
region-of-interest  isocenter  
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Two-dimensional dose matrices were exported from Pinnacle3 to SigmaPlot®.  Isodose curves and 
central-axis depth-dose curves were generated in SigmaPlot®.  For comparison purposes, these curves were 
aligned with respect to the back edge of the plastic water®, which corresponded to the back edge of the 
dose grid (Figure 9).  Because the dose grid was 15.8 cm in the anterior-posterior direction and the 
phantom was 10 cm in the same direction, the first 5.8 cm of the dose matrix were subtracted in order to 
align the isodose curves.  This assured that the 0 cm depth for the depth dose and isodose curves 
corresponded to the surface of the plastic water® in the kVCT image set.  The following is the equation 
used to determine the phantom’s surface (i.e. 0.0 cm in SigmaPlot®) with PS defined as phantom surface, 
DG defined as the length of the dose grid in the anterior-posterior direction, PT defined as the phantom 
thickness in the same direction and FG defined as the front coordinate of the dose grid, placed at -5.8: 
PS = DG – PT + FG. 
 
Figure 9.  The dose grid (green dash line) on a kVCT image with the posterior edge at the posterior edge of 
phantom.   
 
3.2.2 Comparison methods 
 For each beam energy, the MVCT isodose distributions and central-axis depth dose curves were 
superimposed onto the kVCT curves for visual comparison.  Dose differences between the two matrices 
were computed in SigmaPlot® by subtracting the MVCT calculated doses from those of the kVCT.  Dose 
differences were only evaluated in the uniform-dose region.  The range of dose differences was extracted 
and recorded.   
Distance-to-agreement (DTA) was determined for high dose-gradient regions by manual 
measurement with a ruler normal to the superimposed isodose distributions.  The maximum DTA for each 
comparison was recorded.  The uniform dose region is defined as those doses >90% of the maximum dose 
along the central-axis for a 10x10 cm2 open field at 100 cm SSD and the high dose-gradient region is 
defined as 10%<doses <90% of the maximum dose along the central-axis for a 10x10 cm2 open field at 100 
cm SSD.    
3.3 Results 
The superimposed isodose distributions and depth doses are shown in Figures 10-13.  The 
positions of maximum dose difference are identified with a red ellipse.  The positions of maximum DTA 
are identified with a blue ellipse.  The ranges of dose differences and maximum DTAs are shown in Table 
4.  As can be seen the dose differences and DTAs fell within the hypothesis criteria for both energies (<5% 
and ±2 mm, respectively).    
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Figure 10.  9 MeV isodose curves computed on MVCT and kVCT images.  The field size was 10x10 cm2 
and the SSD = 100 cm. 
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Figure 11.  9 MeV percent depth-dose curves for doses computed on MVCT (dashed curve) and kVCT 
(solid curve) images.
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Figure 12.  16 MeV isodose curves computed on MVCT and kVCT images.  The field size was 10x10 cm2 
and the SSD = 100 cm. 
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Figure 13.  16  MeV depth-dose curves for doses computed on MVCT (dashed curve) and kVCT (solid 
curve) images. 
 
 
 
Table 5.  Ranges of dose differences in the uniform-dose region and maximum DTAs in high dose-gradient 
regions. 
Energy 
Ranges of dose 
differences (%) 
(uniform-dose region) Maximum DTA (mm) (gradient regions) 
9 MeV [2.2, -1.3] 0.8 
16 MeV [2.3, -1.2] 1.2 
 
 
 
3.4 Conclusion 
The results demonstrated that TomoTherapy MVCT images for a plastic water phantom can 
produce electron beam dose calculations clinically equivalent as those produced from kVCT images. 
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Chapter 4 Aim 3 
 
4.1 Aim 3:  Compare dose calculations in MVCT and kVCT images of a head phantom and patient 
The goal of Aim 3 was to evaluate the accuracy of electron beam dose calculations in MVCT 
images of an anthropomorphic head phantom and a patient case, both without high-density skin 
collimation. 
4.2 Methods and materials 
A radiosurgery head phantom, CIRS model 605, was chosen to provide a CT data set for phantom 
dose calculations (Fig 14).  This phantom was scanned once on a GE Lightspeed RT machine (2.5 mm slice 
thickness) and once on a TomoTherapy MVCT unit (2.5 mm slice thickness).  Both image sets were 
exported to a Pinnacle3 workstation for treatment planning (Figs 15, 16).  The advantage of using a head 
phantom is that the anatomy is physically the same in both the kVCT and MVCT scans and the images 
could be taken with the same slice thickness.   
 
 
Figure 14.  Photograph of CIRS model 605 radiosurgery head phantom. 
 
 
 
 
Figure 15.  Axial kVCT image of CIRS model 605 radiosurgery head phantom with labeled anatomy.  This 
slice was chosen for the central axis of the electron beam. 
 
zygomatic arch 
maxillary sinus 
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Figure 16.  Axial MVCT image of CIRS model 605 radiosurgery head phantom with labeled anatomy.  
This slice was chosen for the central axis of the electron beam. 
 
 Doses were also calculated on MVCT and kVCT images of a patient.  The selected patient had a 
squamous cell carcinoma of the floor of tongue, had been scanned on a GE Lightspeed (2.5 mm slice 
thickness), and was currently undergoing radiation treatment on the TomoTherapy system.  The daily 
MVCT scan (4 mm slice thickness) taken for IGRT was selected.  Both the kVCT and MVCT images were 
exported to a Pinnacle3 workstation.  The kVCT image set was changed to make a new image set with a 
slice thickness of 5 mm.  This was done by averaging two slices to make one.  This reduced some of the 
potential effects that different slice thicknesses could have on the dose calculation comparison.  Because 
the two image sets were taken approximately 2 months apart, some anatomical differences were observed 
(Figs 17, 18).  The clinical kVCT number-to-density conversion table was used for kVCT dose 
calculations.  The MVCT number-to-density conversion table created on November 13 was used for dose 
calculation purposes. 
 
 
Figure 17.  Axial kVCT image of the patient.  This slice was chosen for the central axis of the electron 
beam. 
zygomatic arch 
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Figure 18.  Axial MVCT image of the patient.  This slice was chosen for the central axis of the electron 
beam. 
 
4.2.1 Image registration 
In Pinnacle3 the two phantom and two patient image sets were manually registered using the 
Image Fusion module.  The fusion process in Pinnacle3 can be done automatically using a local correlation 
algorithm.  However, manual registration was used for two reasons.  First, both image sets must have the 
exact same treatment delivered.  Therefore, any rotation during registration must be known exactly because 
the angle of the gantry with respect to the image must be the same.  The automatic registration algorithm 
does not give the rotation information. Second, the software used to generate isodose curves from the 
exported dose grid information (SigmaPlot® 9.0) does not have a rotation capability for its two dimensional 
contour graphs, so the degree of rotation of the automatic fusion could not be matched even if the amount 
were known.  In the manual registration process, no rotations were used and the fusion of the images was 
done using anatomy in the region of treatment. 
4.2.2 Phantom and patient treatment planning  
The head phantom and patient CT images were treated with the same setup.  The axial slices 
chosen for the central axes (CAX) of the beams included both bone and air inhomogeneities and had 
anatomy conducive to manual registration of the kVCT and MVCT image sets (Figs. 15-18).  Two simple 
treatment plans were created on each image set.  Both plans were open beams with a 6x6 cm2 applicator at 
a gantry angle of 125º and an SSD of 100 cm.  One was a 9 MeV beam and the other a 16 MeV beam.  The 
oblique angle for this beam was chosen to include both bone and air heterogeneities.  The prescription was 
set to 100 MUs.   
 Calculated doses were compared in the axial slice containing the isocenter of the beam.  Doses 
were not evaluated in superior or inferior slices for the patient for two reasons.  First, the patient’s head was 
not in exactly the same location for both the kVCT and MVCT scans and, therefore, image sets could only 
be accurately registered in one slice by using the anatomy in the region of treatment.  Second, because the 
kVCT and MVCT scans had different slice thicknesses, the closest superior and inferior slices that were at 
the same physical locations were 2cm above and below the isocenter.  This distance increased the 
inaccuracies associated with registration of local anatomy.  The dose grid information for each axial slice 
was exported to Sigma Plot® and isodose plots were generated.   
4.2.3 Comparison methods 
The maximum dose differences in the uniform region were calculated by subtracting the MVCT 
calculated dose matrix from the kVCT calculated dose matrix and then finding the differences with the 
largest absolute values.   
4.3 Results 
4.3.1 Phantom treatment plans (9, 16 MeV) 
Figures 19-24 show the central axis axial slices of the kVCT and MVCT image sets with the 
isodose curves, beam profile and isocenter displayed in order to give proper anatomical orientation to the 
zygomatic arch 
maxillary sinus 
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corresponding isodose curves displayed in SigmaPlot®.  On the SigmaPlot® overlays, the position of 
maximum dose difference is indicated by a red ellipse.  The position of maximum DTA is indicated by a 
blue ellipse. 
 
Figure 19.  Axial kVCT image of head phantom with isodose curves, beam profile, and isocenter (9 MeV). 
 
 
Figure 20.  Axial MVCT image of head phantom with isodose curves, beam profile, and isocenter (9 MeV). 
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Figure 21.  Isodose curve comparison for phantom case (9 MeV).  The red ellipse indicates the position of 
maximum dose difference.  The blue ellipse indicates the positions of maximum DTA. 
 
 
Figure 22.  Axial kVCT image of head phantom with isodose curves, beam profile, and isocenter (16 
MeV). 
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Figure 23.  Axial MVCT image of head phantom with isodose curves, beam profile, and isocenter (16 
MeV). 
 
 
Figure 24.  Isodose curve comparison for phantom case (16 MeV).  The red ellipse indicates the position of 
maximum dose difference.  The blue ellipse indicates the positions of maximum DTA. 
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 The ranges of dose differences in the uniform region were calculated by subtracting the MVCT 
calculated dose matrix from the kVCT calculated dose matrix and then finding the differences with the 
largest absolute values.  The results are shown in Table 6.  Both the low energy (9 MeV) and the high 
energy (16 MeV) beams meet the hypothesis criteria of ±5% dose difference in the uniform region and ±2 
mm DTA in the high dose-gradient region.  These results are similar to the plastic water® case. 
 
Table 6. Ranges of dose differences for the head phantom in the uniform region and maximum DTAs in the 
high dose-gradient regions. 
Ranges of dose 
difference (%) Maximum DTA (mm) 
Energy (uniform-dose region) (gradient regions) 
9 MeV [1.2, -2.0] 0.5 
16 MeV [4.3, -2.0] 1.0 
 
 
4.3.2 Patient treatment plans (9, 16 MeV) 
Figures 25-30 show the central axis axial slices of the kVCT and MVCT image sets of the patient 
with the isodose curves, beam profile and isocenter displayed in order to give proper anatomical orientation 
to the corresponding isodose curves displayed in SigmaPlot®. 
 
 
Figure 25.  Patient’s central axis kVCT slice with isodose curves (9 MeV).   
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Figure 26.  Patient’s central axis MVCT slice with isodose curves (9 MeV).  
 
 
 
 23
 
Figure 27.  Isodose curve comparison for patient case (9 MeV).  The red ellipse indicates the position of 
maximum dose difference.  The blue ellipse indicates the positions of maximum DTA. 
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Figure 28.  Patient’s central axis kVCT slice with isodose curves (16 MeV). 
 
 
Figure 29.  Patient’s central axis MVCT slice with isodose curves (16 MeV). 
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Figure 30.  Isodose curve comparison for patient case (16 MeV).  The red ellipse indicates the position of 
maximum dose difference.  The blue ellipse indicates the positions of maximum DTA.  
 
 The range of dose differences in the uniform region was calculated by subtracting the MVCT 
calculated dose matrix from the kVCT calculated dose matrix and then finding the differences with the 
largest absolute values.  The results are shown in Table 7.  Both the low energy (9 MeV) and the high 
energy (16 MeV) beams meet the hypothesis criteria of ±5% dose difference in the uniform region.  These 
results are similar to the phantom case. 
The maximum DTA for doses less than 90% of maximum exceeds ±2 mm for both energies 
(Table 7).  It is important to note that the DTA which did not meet the ±2 mm criteria were found at the 
10% isodose lines.  Not only is this region not as clinically relevant as the target region but this disparity 
may be the results of anatomical changes.  Because the patient was scanned on the Lightspeed machine 
approximately 2 months prior to the TomoTherapy unit scan, it is possible that the anatomy changed to the 
point where dose calculations were affected.  That this is true at least in some regard is seen by examining 
the patient’s right maxillary sinus on the kVCT and MVCT scans.  In the kVCT image the sinus is partially 
filled with fluid while in the MVCT image the fluid is not present.  While this does not directly impact the 
dose calculation in the region of the target, it suggests that there were changes in anatomy that could have 
affected the dose calculations.  Also, the difference in slice thicknesses may have caused inaccuracies in the 
dose calculations.  Results from attempting to quantify this possibility were inconclusive as the patient was 
not able to be scanned at 2.5 mm slice thickness on the TomoTherapy unit.   
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Table 7. Ranges of dose differences for the patient in the uniform region and maximum DTAs in the high 
dose-gradient regions. 
Ranges of dose 
difference (%) Maximum DTA (mm) 
Energy (uniform-dose region) (gradient regions) 
9 MeV [4.4, -2.4] 3.0 
16 MeV [4.0, -2.5] 3.9 
4.4 Conclusions 
4.4.1 Phantom study 
The results for the phantom study indicate that calculated doses from electron beams in complex 
geometrical cases are accurate in MVCT images between 9 MeV and 16 MeV.  The higher energy case 
results were slightly worse than for those of the low energy case but still fell well within the hypothesis 
criteria. 
4.4.2 Patient study 
The results for the patient study suggest that calculated doses from electron beams are not accurate 
in MVCT images.  Both energies failed the hypothesis criteria in having DTA that were greater than 2mm.  
However, it is highly likely that the major cause of the dose disagreements was either a change in the 
anatomy between the time of kVCT imaging and MVCT imaging or slice thickness difference.  The DTA 
values are outside the target, essentially by definition.  The dose differences in the target were within ±5%.  
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Chapter 5 Aim 4 
 
5.1 Aim 4:  Construction of Cerrobend® masks to simulate the range of skin collimation used in the 
clinic 
Cerrobend® masks were needed for testing MVCT images with skin collimation (Aim 5).   Clinically used 
masks were studied and a set of representative test masks was made for use in Aim 5. 
5.2 Methods and materials 
5.2.1 Clinical masks 
A typical patient Cerrobend® mask is shown in Fig 31.  The important characteristics of a mask 
are the opening size, the thickness, and the lateral extent.  The opening size is critical and is determined by 
the size of the treatment area.  The thickness is determined by the beam energy.  It must equal or exceed the 
minimum thickness needed to stop the electron beam.  The lateral extent of the mask is not a precisely 
defined dimension. It needs to be large enough to meet the minimum shielding criteria and not so large as 
to be uncomfortable for the patient.   
 
 
Figure 31.  Photograph of typical clinical Cerrobend® mask. 
 
 However, we expect that the amount of Cerrobend® on the patient will directly impact the quality 
of the MVCT image.  The size of the opening affects the portion of the CT image in the path of the beam, 
with smaller openings having a greater impact than larger openings (Fig 32, 33).  Therefore, it is important 
to perform testing with masks that represent the range of clinical situations.  
 
Figure 32. Cerrobend® mask with a 10x10 cm2 opening on the surface of CIRS plastic water®.    
 
skin 
collimation 
flat surface 
plastic water®
opening  
lateral extent 
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Figure 33.  Cerrobend® mask with a 3x3 cm2 opening on the surface of CIRS plastic water®.    
 
 Twelve clinical Cerrobend® masks used for patient treatment were collected, measured, and 
characterized.  The opening size was approximated as an ellipse and its major and minor axes dimensions 
were measured.  The lateral extent was measured at each end of the major and minor axes.  Masks with 
very small openings, such as those used for treatments involving the eyelid, were not included because in 
such cases the monitor units (MUs) are calculated by hand instead of using treatment planning software. 
5.2.2 Construction of test masks 
Three styrofoam squares were cut by the Compu●cutter® system with sizes of 3x3 cm2, 6x6 cm2 
and 10x10 cm2.  These squares were placed inside steel frames of size 10x10 cm2, 15x15 cm2 and 15x15 
cm2 respectively.  Cerrobend® was poured around the foam squares and made to the desired thickness (6 
mm, 8 mm, and 10 mm) required for adequate shielding for energies of 6, 9, 12, and 16 MeV (Fig 34).  
This process produced a total of nine square masks with clinically relevant opening sizes, lateral extensions 
and thicknesses (Table 8).  
 
 
Figure 34.  Cerrobend® mask formed within the steel frame and around a styrofoam insert. 
 
Table 8.  Constructed mask dimensions. 
Mask number Opening size (cm2) Lateral extent (cm) Thickness (mm) 
1 3x3 3.5 6 
2 6x6 4.5 6 
3 10x10 2.5 6 
4 3x3 3.5 8 
5 6x6 4.5 8 
6 10x10 2.5 8 
7 3x3 3.5 10 
8 6x6 4.5 10 
9 10x10 2.5 10 
 
 
 
skin collimation 
plastic water®
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steel frame   
Cerrobend® 
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5.3 Results 
The characteristics of the individual clinical masks are given in Table 9.  As can be seen, the 
dimensions varied considerably.  The data are summarized in Table 10, which shows the maximum, 
minimum and average values for the lateral extent and opening size.  These values guided the dimensions 
of the Cerrobend® masks produced in this aim for the tests of Aim 5.  Smaller dimensions were chosen for 
the lateral extent of the test masks with respect to the clinical sizes because clinical masks are often made 
larger than necessary in this region to avoid any possible shielding problems.  Examples of the test masks 
are shown in Figures 35-38. 
 
Table 9.  Dimensions of clinical Cerrobend® masks. 
 Clincial mask 
dimensions Opening  size (cm) Lateral  extent (cm) 
Mask number major axis minor axis 
major axis 
ends minor axis ends 
1 7.5 5.0 5.0  ,  5.5 4.5  ,  6.0 
2 8.0 7.0 4.0  ,  3.5 4.5  ,  4.0 
3 7.0 6.0 4.5  ,  4.0 4.5  ,  4.5 
4 8.0 6.0 5.0  ,  5.0 5.0  ,  5.0 
5 11.0 10.0 3.0  ,  4.0 3.0  ,  4.0 
6 13.0 6.0 4.5  ,  3.5 5.5  ,  5.0 
7 2.5 2.0 5.0  ,  7.0 5.0  ,  5.5 
8 4.0 2.0 6.0  ,  4.0 6.0  ,  5.0 
9 6.0 6.0 6.0  ,  6.0 6.5  ,  5.0 
10 12.5 8.0 3.0  ,  3.0 4.0  ,  4.0 
11 4.5 4.0 3.5  ,  3.5 3.5  ,  3.5 
12 6.0 3.5 3.5  ,  4.0 4.0  ,  4.0 
 
Table 10.   Maximum, minimum and mean clinical mask dimensions. 
Clinical mask data Maximum distance (cm) Minimum distance (cm) Mean distance (cm) 
Lateral Extent       
major axis 7.0 3.0 4.4 
minor axis 6.0 3.0 4.7 
        
Opening Size       
Major axis 13.0 2.5 7.5 
minor axis 10.0 2.0 5.5 
 
 
    
Figure 35.  Photograph of a mask with Figure 36.  Photograph of a mask with a 
a 3x3cm2 opening. 6x6 cm2 opening.    
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Figure 37.  Photograph of a mask with Figure 38.  Photograph showing a 6 mm 
a 10x10 cm2 opening.  thick mask next to a 10 mm thick mask. 
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Chapter 6 Aim 5 
 
6.1 Aim 5:  Comparison of dose calculations in MVCT and kVCT images with skin collimation. 
The purpose of this aim was to evaluate the accuracy of dose calculations in MVCT images with 
skin collimation. 
6.2 Methods and materials 
Two slabs of 30x30x5 cm3 CIRS plastic water® (density=1.03g·cm-3), used clinically for machine 
QA, were stacked on top of each other to provide a simple geometry phantom that could easily be CT 
scanned with or without the Cerrobend® masks. 
6.2.1 kVCT treatment planning 
The two slabs were scanned on a GE Lightspeed RT machine (120 kvp, 2.5 mm slice thickness) 
and exported to a Pinnacle3 workstation.  In Pinnacle3, regions-of-interest (ROIs) were created on the 
surface of the phantom to mimic the nine different masks created in Aim 4 (Fig 39).  Because only one 
image set was used in Pinnacle3 and a total of nine different treatment fields needed to be simulated, the 
treatment planning was performed in stages.  After each collimation ROI was formed, the corresponding 
treatment field was created, the dose was calculated, and the result was exported to SigmaPlot®.   
 
  
          (a)               (b) 
 
Figure 39.  (a) Axial view of ROI Cerrobend® in kVCT image; beam edges are in red.  (b) Beam’s eye view 
of ROI Cerrobend® in kVCT image; beam outline is in red. 
 
 Two important modifications were made to ensure that the ROIs behaved as skin collimation in 
the dose calculations.    The first modification required creating a special table in Pinnacle3 for computing 
stopping power ratios and scattering power ratios from patient density.  Pinnacle3 uses a look-up table to 
convert densities to collision stopping power and angular scatter power ratios for the purpose of electron 
dose calculation. However, Pinnacle3 limits densities in this table to a maximum value of 3 g·cm-3. This is 
not high enough to correctly model Cerrobend®.  Collision stopping power and angular scattering power 
ratios for Cerrobend® were chosen to be 11.3 and 11.9 respectively based on work done previously by Dr. 
Kenneth Hogstrom12.  The workaround for this problem was to insert those values into the table for a 
corresponding density value of 2.9 g·cm-3 (Table 11).  These values would allow Pinnacle3 to terminate the 
transport of electrons through the ROIs mimicking Cerrobend®.  The second modification was to make the 
density of the ROI equal to the highest density value allowed by Pinnacle3 (3 g·cm-3). 
 
 
 
 
 
 
 
 
 
 
 
 
plastic water® 
phantom ROI skin 
collimation 
skin  
collimation 
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Table 11.  Patient collision stopping power and angular scattering power data. 
Physical Density 
(g·cm-3)        Collision Stopping Power Ratio Angular Scattering Power Ratio 
0.000 0.001 0.001 
0.291 0.311 0.292 
0.927 0.933 0.729 
1.000 1.027 0.912 
1.047 1.051 1.040 
1.100 1.098 1.135 
1.427 1.422 1.863 
1.940 1.940 3.026 
2.900 11.300 11.900 
 
6.2.2 MVCT treatment planning 
The two slabs were also scanned with each of the nine Cerrobend® masks on the TomoTherapy 
unit and exported to the Pinnacle3 treatment planning station.  This was completed over a period of two 
days. For each day an MVCT number-to-density table was created as mentioned in Aim 1.  Figure 40 
shows one of the masks on the plastic water® phantom. 
 
    
          (a)                (b) 
Figure 40.  (a) Beam’s eye view of Cerrobend® mask on top of CIRS plastic water® phantom.  (b) 
Lateral view of Cerrobend® on top of CIRS plastic water® phantom.   
 
6.2.3 Density versus depth 
 The penetration of a radiation beam in a given material depends in part on the density of that 
material.  The density of an object that has been CT scanned is determined by converting the measured CT 
number to a density according to a CT number-to-density calibration curve.  Therefore, distortions in 
imaging that cause changes in the CT numbers will result in corresponding density changes and 
corresponding changes in calculated doses. 
 In order to assess the impact of the skin collimation on the distortion of density, density was 
measured as a function of depth along the central axis of the treatment beams. Because of inherent noise in 
the images, CT numbers were averaged within ROIs created on the kVCT image set and on each MVCT 
image set to provide a mean density (Fig 41).  A total of 16 ROIs were created on image sets with treatment 
beams of 6-12 MeV and 20 ROIs were created on image sets with a 16 MeV beam.  The ROIs were 
cuboids with dimensions of 1x0.4 cm2 and a thickness equal to the slice thickness.  The mean density was 
computed in each of these ROIs using Pinnacle3 and assigned to the depth at the center of the ROI.    
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Figure 41.  Central axis ROIs on MVCT image.  
 
 The mean densities were also used to obtain a radiological depth versus dose curve along the 
central axis.  The radiological depth is defined as the sum over segments of the product of the segment 
length and the inhomogeneity density of the region corresponding to the segment and was calculated at 
each dose point by a simple equation (Siddon et al).  The mean density of each ROI (ρROI), the physical 
thickness of each ROI (∆d), and the physical depth at the center of each ROI (di) were used to compute the 
radiological depth (deq, i) at the center of each ROI from the following equations: 
 
for n=1 
1,1, *2 ROIeq
dd ρ∆=  
 
for n>1 
}{*
2 ,1,21,, iROIiROI
n
ieqneq
ddd ρρ +∆+= −=∑ . 
The dose at the center of each ROI (Di) was calculated by Pinnacle3 and the radiological depth and dose 
values were used to create the plot (Di vs. deq, i).                  
     
 
 
6.2.4 Dose extraction methods 
Dose grids of identical dimensions were defined for all CT image sets. Then, the kVCT and 
MVCT image sets were registered spatially by aligning the posterior edge of the dose grid to the posterior 
edge of the plastic water® (Figure 42).  The coordinate of the posterior edge of the plastic water® in both 
CT sets was determined by the same two step process outlined in Aim 2.  This method put the dose grid in 
the same position relative to the phantom regardless of possible distortions in the anterior surface of the 
images due to the skin collimation. 
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Figure 42.  The dose grid (green dash) on an MVCT image with the posterior edge at the posterior edge of 
phantom. 
 After the matrices were imported into SigmaPlot® from the Pinnacle3 workstation, the depth dose 
and isodose curves were aligned with respect to the back edge of the plastic water®, which corresponded to 
the back edge of the dose grid.  This assured that the 0 cm depth for the depth dose and isodose curves 
corresponded to the surface of the plastic water® in the kVCT image set.  
6.2.5 Treatment planning 
A total of twelve treatments were planned on the nine different kVCT configurations and the nine 
MVCT scanned image sets.  Each plan contained an electron beam at an SSD of 100cm, with a prescription 
of 100 monitor units and included the mask of corresponding size and thickness (Table 12). 
 
Table 12.  Treatment plans delivered to MVCT image sets. 
Treatment plan Opening size (cm2) Beam energy (MeV) Mask thickness (mm) SSD (cm) MUs 
1 3x3 6 6 100 100 
2 3x3 9 6 100 100 
3 3x3 12 8 100 100 
4 3x3 16 10 100 100 
5 6x6 6 6 100 100 
6 6x6 9 6 100 100 
7 6x6 12 8 100 100 
8 6x6 16 10 100 100 
9 10x10 6 6 100 100 
10 10x10 9 6 100 100 
11 10x10 12 8 100 100 
12 10x10 16 10 100 100 
 
 Central-axis depth dose curves and isodose curves were compared in the central axial xz-plane. 
Doses were taken directly from the planning system.  No normalizations were applied.  Dose comparisons 
were evaluated using the same criteria as used in Aims 2 and 3. In the uniform-dose region, dose 
differences were computed and in high dose-gradient regions, distance-to-agreement (DTA) was measured. 
The maximum dose difference in the uniform region was calculated by subtracting the MVCT calculated 
dose matrix from the kVCT calculated dose matrix.  The DTAs were measured on superimposed hard 
copies of isodose plots for each opening and energy. It is noted that there are some large discrepancies in 
the penumbra region just lateral to the edges of the skin collimation.  This is due in part to the fact that the 
Pinnacle3 pencil beam algorithm has pencil beams that are 2x2 mm2.  This means that there is a ±1 mm 
uncertainty in position of the calculated doses at the edge of the beam.  Also, the MVCT images show some 
distortion at the edges of the Cerrobend® mask.  They appear slightly rounded when in fact the edges are 
straight (Fig 43).  This adds to the uncertainty in calculated dose at the edge of the collimation. 
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Figure 43.  Axial MVCT image showing distorted (rounded) edges of Cerrobend® skin collimation (3x3 
cm2, 10 mm).  
 
6.3 Results 
6.3.1 Small opening (3x3 cm2)  
Overlays of the MVCT and kVCT isodose distributions are shown in Figs 44-47.  The central axis 
depth doses are shown in Figs 48-51.  Table 12 gives the range of dose differences in the uniform-dose 
region.  There is no instance in which the maximum dose differences meet the hypothesis criterion.  All 
cases fail to meet the criterion and the maximum error is largest in the 12 MeV case, which is the energy 
with the highest peak in dose along the central axis. 
 The maximum DTAs in the high dose-gradient regions are also shown in Table 13.  In no instance 
are they within ±2 mm.  For the 12 MeV and 16 MeV beams, the maximum DTAs are well above ±2 mm.  
In addition, the maximum DTA also increases with increasing beam energy. 
 
Table 13.  Ranges of dose differences for the 3x3 cm2 opening in the uniform-dose region and maximum 
DTAs in high dose-gradient regions. 
3x3cm2 
opening 
Ranges of dose differences (%) 
(uniform-dose region) 
Maximum DTA (mm) 
(gradient regions) 
6 MeV 2.8,  -6.3 3.2 
9 MeV 2.7, -6.7 4.0 
12 MeV 5.0, -11.8 6.3 
16 MeV 5.9, -7.5 7.3 
 
The central-axis depth doses highlight some aspects of the comparison that are not readily 
apparent in the maximum dose differences and maximum DTA measurements.  The depth doses show a 
decreasing penetration of the beam in the MVCT images relative to the kVCT images as the energy 
increases. In addition, there is a peaking phenomenon for the MVCT calculated doses.  The highest peak 
occurs for the 12 MeV beam and the longest peak occurs for the 16 MeV beam.  This peaking is unique to 
the small opening case and will be discussed in the analysis section.    
  
rounded edge 
 36
 
 
 
 
Figure 44.  MVCT and kVCT calculated isodose comparison (3x3 cm2, 6 MeV). 
Figure 45.  MVCT and kVCT calculated isodose comparison (3x3 cm2, 9 MeV). 
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Figure 47.  MVCT and kVCT calculated isodose comparison (3x3 cm2, 16 MeV). 
Figure 46.  MVCT and kVCT calculated isodose comparison (3x3 cm2, 12 MeV). 
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Figure 48.  MVCT and kVCT calculated depth dose curve comparison (3x3 cm2, 6 MeV). 
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Figure 49.  MVCT and kVCT calculated depth dose curve comparison (3x3 cm2, 9 MeV). 
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Figure 50.  MVCT and kVCT calculated depth dose curve comparison (3x3 cm2, 12MeV). 
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Figure 51.  MVCT and kVCT calculated depth dose curve comparison (3x3 cm2, 16 MeV). 
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6.3.2 Medium opening (6x6cm2) 
Overlays of the MVCT and kVCT isodose distributions are shown in Figs 52-55.  Depth dose 
curves along the central axis are shown in Figs 56-59.  Table 14 gives the range of dose differences in the 
uniform-dose region.  The maximum dose differences fail to meet the hypothesis criterion (±5%) for all 
beams.  The maximum DTAs in the high dose-gradient regions fail to be within ±2 mm for all energies 
(Table 14).  However, the maximum DTAs clearly agree much better than those of the small opening. 
 
Table 14.  Ranges of dose differences for the 6x6cm2 opening in the uniform-dose region and maximum 
DTAs in high dose-gradient regions. 
Ranges of dose 
differences (%) Maximum DTA (mm) 
6x6cm2 
opening 
(uniform-dose 
region) (gradient regions) 
6 MeV 6.3, -5.3 2.7 
9 MeV 5.2, -7.6 3.0 
12 MeV 5.1, -2.6 3.7 
16 MeV 3.2, -13.7 3.7 
 
 
 
Comparison of the central-axis depth dose curves shows very good agreement in the penetration of 
the higher energy beams.  Similar to the 3x3 cm2 opening MVCT depth dose curves, the curves for this 
opening penetrate less deeply than those of the kVCT.  However, in this case, the curves agree much better 
especially for the lower energies.  There also appears to be less variation in the difference with beam 
energy. It should be noted that in the low energy range (6-12 MeV) there is none of the peaking that 
occurred for the small opening beams.  A slight peak occurs in the high energy (16 MeV) beam and this 
will be discussed in the analysis section. 
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Figure 52.  MVCT and kVCT calculated isodose comparison (6x6 cm2, 6 MeV). 
Figure 53.  MVCT and kVCT calculated isodose comparison (6x6 cm2, 9 MeV). 
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Figure 54.  MVCT and kVCT calculated isodose comparison (6x6 cm2, 12 MeV). 
Figure 55.  MVCT and kVCT calculated isodose comparison (6x6 cm2, 16 MeV). 
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Figure 56.  MVCT and kVCT calculated depth dose curve comparison (6x6 cm2, 6 MeV). 
.   
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Figure 57.  MVCT and kVCT calculated depth dose curve comparison (6x6 cm2, 9 MeV). 
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Figure 58.  MVCT and kVCT calculated depth dose curve comparison (6x6 cm2, 12 MeV). 
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Figure 59.  MVCT and kVCT calculated depth dose curve comparison (6x6 cm2, 16 MeV). 
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6.3.3 Large opening (10x10cm2) 
Overlays of the MVCT and kVCT isodose distributions are shown in Figs 60-63).  Depth dose 
curves along the central axis are shown in Figs 64-67.  Table 15 gives the range of dose differences in the 
uniform-dose region.  In all cases, the maximum dose differences exceeded ±5%. The maximum dose 
differences appear to be essentially independent of beam energy.     
 The maximum DTA was greater than ±2 mm for all energies except 16MeV (Table 15).  However, 
the low energies (6, 9MeV) were close to meeting the hypothesis criterion.   
 
Table 15.  Ranges of dose differences for the 10x10 cm2 opening in the uniform-dose region and maximum 
DTAs in high dose-gradient regions. 
Ranges of dose 
differences (%) Maximum DTA (mm) 10x10cm2 
opening (uniform-dose region) (gradient regions) 
6 MeV 4.8, -5.4 2.0 
9 MeV 3.9, -5.5 2.0 
12 MeV 4.5, -1.1 2.3 
16 MeV 4.9, -2.8 1.7 
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Figure 60.  MVCT and kVCT calculated isodose comparison (10x10 cm2, 6 MeV). 
 
Figure 61.  MVCT and kVCT calculated isodose comparison (10x10 cm2, 9 MeV). 
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Figure 62.  MVCT and kVCT calculated isodose comparison (10x10 cm2, 12 MeV). 
 
Figure 63.  MVCT and kVCT calculated isodose comparison (10x10 cm2, 16 MeV). 
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The shapes of the MVCT and kVCT central-axis depth dose curves (Figs 64-67) are very similar 
but the MVCT curves are shifted to greater depth.  The amount of shift appears to be essentially 
independent of beam energy. In addition, there is no peaking in the MVCT calculated dose as was seen for 
the small opening beams. 
 
 
Figure 64.  MVCT and kVCT calculated depth dose curve comparison (10x10 cm2, 6 MeV). 
 
 
6.3.4 Density versus depth plots 
 In Figures 68-70, the mean density in ROIs along the central axis is shown as a function of depth 
for the different mask openings and thicknesses.  For comparison, the mean density in ROIs along the 
central axis as a function of depth is shown for the kVCT image without skin collimation.  
 For the small opening, mean densities along the central axis are much higher than the 
corresponding kVCT densities reaching a maximum increase of about 10% over kVCT values for the 10 
mm mask.  The MVCT densities show a slight trend toward increasing values with increasing mask 
thickness.      
For the medium opening central axis densities are slightly higher in the MVCT images compared 
to the kVCT images. The maximum density for the MVCT images is only approximately 3% higher than 
the kVCT values.  There is little variation in density with mask thickness except at the most superficial 
depths (0-2 cm).  
 For the large opening, the mean MVCT densities are slightly lower than the kVCT densities at the 
superficial depths (0-3.5 cm).  At 1-3 cm depth, they are as much as 3% low.  In that depth range, there is 
some variation in density with mask thickness.  At greater depths (>6cm), the MVCT densities are slightly 
greater than the kVCT densities, but too deep to affect electron doses.   
It is interesting that the density versus depth curves seem to have two plateaus.  Up to about 4 cm 
depth, the MVCT densities show a larger variation with opening size than at greater depths.  This suggests 
that the skin collimation produces greater distortions at shallower depths, not a surprising result. 
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Figure 65.  MVCT and kVCT calculated depth dose curve comparison (10x10 cm2, 9 MeV). 
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Figure 66.  MVCT and kVCT calculated depth dose curve comparison (10x10 cm2, 12 MeV). 
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Figure 67.  MVCT and kVCT calculated depth dose curve comparison (10x10 cm2, 16 MeV). 
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Figure 68.  Density versus depth curve for the 3x3 cm2 opening.  
 
 
Figure 69.  Density versus depth curve 6x6 cm2 opening. 
 
 
Figure 70.  Density versus depth curve 10x10 cm2 opening. 
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6.3.5 Dose versus radiological depth 
To more directly examine the effects of density distortion on calculated dose, dose was plotted as a 
function of radiological depth along the central-axis of each beam (Fig 71-82).  Radiological depth was 
computed from mean densities as described in the Methods and Material. 
 
6.4 Analysis of results 
With one exception, dose calculations in the MVCT images differed from the kVCT dose 
calculations by more than ±5% in the uniform-dose region for all opening sizes. Agreement in the gradient 
regions was better but still exceeded a distance-to-agreement of ±2 mm in 9 of the 12 plans. The large 
opening showed the best agreement in the gradient regions. 
In examining the depth dose curves for each of the opening sizes, it is clear that the shift of the 
MVCT curve relative to the kVCT curve varies with the size of the opening.  For the small opening, the 
MVCT curves are greatly shifted to shallow depths.  For the medium opening, the MVCT curves are 
shifted to more shallow depths but more closely match the kVCT curves.  For the large opening, the MVCT 
curves are shifted to greater depths.  A peak was also observed in the small opening results as well as a 
small peak in the high energy (16 MeV) case for the medium opening.  These are two separate issues and 
will be discussed separately.   
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Figure 71.  Dose versus radiological depth (3x3 cm2 opening, 6 MeV). 
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Figure 72.  Dose versus radiological depth (3x3 cm2 opening, 9 MeV). 
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Figure 73.  Dose versus radiological depth (3x3 cm2 opening, 12 MeV). 
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Figure 74.  Dose versus radiological depth (3x3 cm2 opening, 16 MeV). 
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Figure 75.  Dose versus radiological depth (6x6 cm2 opening, 6 MeV). 
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Figure 76.  Dose versus radiological depth (6x6 cm2 opening, 9 MeV). 
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Figure 77.  Dose versus radiological depth (6x6 cm2 opening, 12 MeV). 
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Figure 78.  Dose versus radiological depth (6x6 cm2 opening, 16 MeV). 
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Figure 79.  Dose versus radiological depth (10x10 cm2 opening, 6 MeV). 
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Figure 80.  Dose versus radiological depth (10x10 cm2 opening, 9 MeV). 
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Figure 81.  Dose versus radiological depth (10x10 cm2 opening, 12 MeV). 
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Figure 82.  Dose versus radiological depth (10x10 cm2 opening, 16 MeV). 
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6.4.1 Shifted MVCT curves 
The dose shift to shallower depths for the small and medium openings and the shift to greater 
depth for the large opening are due to CT number distortions in the images caused by the presence of 
Cerrobend®.  These distortions in the CT numbers produce distortions in the density of the material, which 
cause the electron beam penetration to change depending on the amount of distortion.    The density versus 
depth plots shown in section 6.3.4 clearly reveal this effect.  Displaying radiological depth versus dose 
removes the effect of distortions in the densities of the phantom. The plots of dose versus radiological 
depth confirm that most, but not all, of the dose differences result from these distortions.  For the medium 
and large openings, these plots are almost identical for the MVCT and kVCT images, confirming that these 
dose differences are due almost entirely to density distortions in the MVCT images of the phantom.  
For the small opening, these density distortions contribute to the dose differences but are not the 
only effect. Comparing the plots of dose versus radiological depth (Figs 75-77) to the corresponding plots 
of dose versus depth (Figs 52-54) show that removing the distortions in the phantom MVCT numbers 
improves the agreement. However, significant differences remain.  The remaining significant differences 
are caused by the second issue, that of peaking.   
 
6.4.2 Peaking in the small opening data 
The residual dose differences are attributed to distortions in the images of the skin collimation in 
the MVCT scans.  In the MVCT images, the internal edges of the skin collimation appear slightly rounded, 
when they are in fact straight (Figure 46).  This artificial rounding causes the dose calculation algorithm to 
overestimate the number of electrons scattered from this inner edge.  The extra scattered electrons deposit 
their dose at superficial depths, including Dmax, and so do not penetrate to the depth that they would if the 
collimation were accurately represented.  This additional scattering from the edge of the collimation can be 
seen in the isodose plots of the larger openings as well.  There are two hot spots located lateral to the 
central-axis in every one of the isodose plots for the 6x6 cm2 and 10x10 cm2 opening beams except for that 
of the 16 MeV beam, 10x10 cm2 opening size (Figs 55-58, 59-61) .  The depth dose plots for the medium 
and large openings are not affected simply because the width of the openings is too great for the collimator-
scattered electrons to reach the center of the field.  The one exception is seen in the high energy (16 MeV), 
with medium opening case where the electrons had enough energy to reach the central axis after being 
scattered off the collimator.  These changes in dose from distortion in the image of the collimator are in 
addition to dose changes due to distortions in the image of the phantom. 
 
6.5 Summary 
Two different effects contribute to the discrepancies between MVCT computed doses and kVCT 
computed doses.  The dominant effect is the distortion in density in the MVCT images caused by the high-
density Cerrobend®.  Although not readily apparent in the MVCT images, the CT numbers below the 
openings in the path of the beam are changed by the presence of the skin collimation.   For the smallest 
opening, the distortion in CT numbers appears as tissue density increases of up to 10%.  With increasing 
opening size, the CT numbers decrease, producing smaller apparent density shifts.  Therefore, the electron 
beam penetration changes with opening size.  A second effect is the distortion of the image of the skin 
collimation.  This distortion causes increases in superficial dose and decreases in dose at depth. 
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Chapter 7 Conclusion 
 
   The hypothesis of this research is that using MVCT images with skin collimation for treatment 
planning, doses delivered from 6-16 MeV electron beams can be calculated to ±5% dose difference 
agreement in the uniform-dose region and ±2mm distance-to-agreement in high dose-gradient regions to 
doses calculated using kVCT images with manually contoured skin collimation.  The uniform dose region 
is defined as those doses >90% of the maximum dose along the central-axis for a 10x10 cm2 open field at 
100 cm SSD and the high dose-gradient region is defined as 10%<doses<90% of the maximum dose along 
the central-axis for a 10x10 cm2 open field at 100 cm SSD.    
 This hypothesis was tested with five specific aims and two related but distinct goals.  Aims 2 and 
3 tested the ability of MVCT images to be used for treatment planning with electron beams without the 
presence of skin collimation.  Aim 5 tested the ability of MVCT images to be used for treatment planning 
with electron beams with skin collimation present. 
 It was found that doses calculated using MVCT images agreed well with doses calculated using 
kVCT images when there was no skin collimation.  It was sufficiently accurate to meet the criteria of the 
hypothesis for the simple geometry phantom and the head phantom.  It failed for the patient case, but that 
may have been due to changes in anatomy during the 2 month interval between the scans. 
When skin collimation was introduced into the MVCT images, the distortions in the phantom 
density and distortions in the image of the skin collimation produced errors that were greater than ±5% and 
maximum DTAs that were greater than ±2 mm in most cases. 
 The results of this research negate the hypothesis that using MVCT images for treatment planning, 
doses delivered from 6-16 MeV electron beams can be calculated with the presence of skin collimation to 
±5% dose difference in the uniform dose region and ±2 mm DTA in dose gradient regions.  Therefore, the 
hypothesis must be rejected. 
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